Last updated: March 18, 2026
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting
Phase
3
Condition
Hypoparathyroidism
Parathyroid Disorders
Treatment
ICG
Control group
Clinical Study ID
NCT04785443
29BRC20.0208
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient having to undergo a total thyroidectomy
Signed consent
Patient beneficiary of a social security regimen
Exclusion
Exclusion Criteria:
Minor patient under 18 years old
Major patient protected by law or unable to give informed consent
Pregnant or breastfeeding woman
Thyroidectomy totalization
History of thyroid or parathyroid surgery
Participation refusal
Known allergy to ICG
Woman of child-bearing age not using adequate method of contraception
Study Design
Total Participants: 242
Treatment Group(s): 2
Primary Treatment: ICG
Phase: 3
Study Start date:
June 22, 2021
Estimated Completion Date:
June 22, 2027
Study Description
Connect with a study center
CHRU de Brest
Brest, 29609
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.